Vantage logo

The US FDA gets tough

Tecentriq follows Opdivo, Imfinzi and Keytruda in having a US approved use knocked out.

Vantage logo

Glaxo fails to win an Oscar

There might be a use for Glaxo’s anti-Covid-19 antibody otilimab in old patients, but repeating Actemra’s trick will not be easy.